Literature DB >> 20848204

HCV-related proteins activate Kupffer cells isolated from human liver tissues.

Naohiro Hosomura1, Hiroshi Kono, Masato Tsuchiya, Kenichi Ishii, Masahito Ogiku, Masanori Matsuda, Hideki Fujii.   

Abstract

PURPOSE: It was reported from this laboratory that Kupffer cells (KCs) were activated in patients infected with HCV. Since dendritic cells, monocytes, and macrophages were activated by stimulation with HCV-related proteins, the specific aim of this study was to investigate the role of HCV-related proteins in activation of KCs, the signal pathway of activation of KCs mediated by Toll-like receptor (TLR) 4, and the influence of HCV infection on function of KCs.
METHODS: Kupffer cells isolated from non-cancerous surgical specimen were co-cultured with HCV-related proteins (Core, NS3, NS4, and NS5), and production of cytokines (TNF-α, IL-1β, and IL-10) and hydrogen peroxide were assessed. Furthermore, effects of neutralization antibodies against the TLR2, TLR3, or TLR4, and cytochalasin B on the production TNF-α by KCs were investigated.
RESULTS: Kupffer cells produced markedly a proinflammatory cytokine TNF-α by stimulation with all HCV-related proteins studied, and values were as same as production by KCs stimulated with LPS. Importantly, this production in the case of NS3 was significantly blunted by about 60% by neutralization antibodies against the TLR4, but not cytochalasin B. Production of TNF-α by isolated KCs stimulated with LPS was significantly greater in the HCV-infected livers than the HCV/HBV-negative livers.
CONCLUSIONS: These results indicated that HCV-related proteins may cause prolonged activation of KCs in the HCV-infected liver, leading to accumulation of inflammatory cytokines that contribute to DNA damage and carcinogenesis. Furthermore, function of KCs was difference between patients infected with and without HCV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848204     DOI: 10.1007/s10620-010-1395-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice.

Authors:  Cynthia Ju; Timothy P Reilly; Mohammed Bourdi; Michael F Radonovich; John N Brady; John W George; Lance R Pohl
Journal:  Chem Res Toxicol       Date:  2002-12       Impact factor: 3.739

Review 2.  Biologically active products of stimulated liver macrophages (Kupffer cells).

Authors:  K Decker
Journal:  Eur J Biochem       Date:  1990-09-11

3.  Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.

Authors:  B Kallinowski; K Haseroth; G Marinos; C Hanck; W Stremmel; L Theilmann; M V Singer; S Rossol
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells.

Authors:  I Rusyn; M B Kadiiska; A Dikalova; H Kono; M Yin; K Tsuchiya; R P Mason; J M Peters; F J Gonzalez; B H Segal; S M Holland; R G Thurman
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

5.  Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride.

Authors:  P Muriel; N Alba; V M Pérez-Alvarez; M Shibayama; V K Tsutsumi
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2001-10       Impact factor: 3.228

6.  Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

Authors:  Angela Dolganiuc; Shilpa Oak; Karen Kodys; Douglas T Golenbock; Robert W Finberg; Evelyn Kurt-Jones; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

Authors:  Fabio Farinati; Romilda Cardin; Marina Bortolami; Maria Guido; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

8.  Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.

Authors:  Serena Chang; Angela Dolganiuc; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2007-06-26       Impact factor: 4.962

9.  Portal and systemic endotoxemia in abdominal operations: the significance of acute abdomen.

Authors:  Diamantis Plachouras; Michalis Stamatakos; Fotini Baziaka; Evangelos Giamarellos-Bourboulis; Thomas Tsaganos; Helen Giamarellou; Michalis Safioleas
Journal:  J Surg Res       Date:  2006-02-07       Impact factor: 2.192

10.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.

Authors:  R S Lin; F Y Lee; S D Lee; Y T Tsai; H C Lin; R H Lu; W C Hsu; C C Huang; S S Wang; K J Lo
Journal:  J Hepatol       Date:  1995-02       Impact factor: 25.083

View more
  25 in total

1.  Featured Article: Isolation, characterization, and cultivation of human hepatocytes and non-parenchymal liver cells.

Authors:  Elisa Pfeiffer; Victoria Kegel; Katrin Zeilinger; Jan G Hengstler; Andreas K Nüssler; Daniel Seehofer; Georg Damm
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-12

Review 2.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

3.  Adenovirus-mediated dual gene expression of human interleukin-10 and hepatic growth factor exerts protective effect against CCl4-induced hepatocyte injury in rats.

Authors:  Hong Qiu; Yan Yan; Jicheng Xing; Yuerong Zhu; Lin Fang; Xiangrong Cao; Changqing Su
Journal:  Dig Dis Sci       Date:  2012-03-08       Impact factor: 3.199

4.  Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes.

Authors:  Banishree Saha; Karen Kodys; Adeyinka Adejumo; Gyongyi Szabo
Journal:  J Immunol       Date:  2017-01-25       Impact factor: 5.422

Review 5.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 6.  Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.

Authors:  Jessica Brownell; Stephen J Polyak
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

Review 7.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

8.  Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.

Authors:  Bing Sun; Linda Abadjian; Alexander Monto; Heather Freasier; Lynn Pulliam
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 5.226

9.  Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection.

Authors:  W O Osburn; J S Levine; M A Chattergoon; D L Thomas; A L Cox
Journal:  J Viral Hepat       Date:  2013-02-06       Impact factor: 3.728

10.  IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.

Authors:  Amina A Negash; Hilario J Ramos; Nanette Crochet; Daryl T Y Lau; Brian Doehle; Neven Papic; Don A Delker; Juandy Jo; Antonio Bertoletti; Curt H Hagedorn; Michael Gale
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.